TORRENT PHARMACEUTICALS
Back to Income Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Operating Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Operating Profit (Excl OI) | ₹2,824 Cr | ₹2,431 Cr | ₹2,480 Cr | ₹2,170 Cr | ₹1,976 Cr |
What is the latest Operating Profit of TORRENT PHARMACEUTICALS ?
Year | Operating Profit |
---|---|
Mar2024 | ₹2,824 Cr |
Mar2023 | ₹2,431 Cr |
Mar2022 | ₹2,480 Cr |
Mar2021 | ₹2,170 Cr |
Mar2020 | ₹1,976 Cr |
How is Operating Profit of TORRENT PHARMACEUTICALS Trending?
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹2,824 Cr | 16.15 | |
Mar2023 | ₹2,431 Cr | -1.97 | |
Mar2022 | ₹2,480 Cr | 14.27 | |
Mar2021 | ₹2,170 Cr | 9.81 | |
Mar2020 | ₹1,976 Cr | - |
Compare Operating Profit of peers of TORRENT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TORRENT PHARMACEUTICALS | ₹109,973.2 Cr | 0.7% | 9.8% | 19.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹424,706.0 Cr | 2.3% | 11.7% | 5.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,946.0 Cr | -1.6% | 4% | 58.7% | Stock Analytics | |
CIPLA | ₹120,751.0 Cr | 0.8% | 6.2% | -2.9% | Stock Analytics | |
MANKIND PHARMA | ₹100,168.0 Cr | -1.4% | 4.5% | 4.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,066.7 Cr | -1% | 2.8% | -8% | Stock Analytics |
TORRENT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TORRENT PHARMACEUTICALS | 0.7% |
9.8% |
19.8% |
SENSEX | -1.3% |
4.2% |
3.6% |
You may also like the below Video Courses